Partners in our M&A Group explore important updates for European dealmakers. They discuss the practical implications of the pandemic crisis on M&A transactions and how some parties may find valuable opportunities. They also explore regulatory issues, such as timing implications in antitrust and other regulatory approvals, and explore trends in foreign investment regulation. Other topics include preparatory steps for a rise in shareholder activism and how boards might assess future M&A proposals.